Section Arrow
ECOR.NASDAQ
- electroCore
Quotes are at least 15-min delayed:2026/03/09 16:41 EDT
After Hours
Last
 6.64
-0.21 (-3.07%)
Bid
6.65
Ask
6.88
High 6.64 
Low 6.64 
Volume
Regular Hours (Closed)
Last
 6.85
0 (0.00%)
Day High 
6.89 
Prev. Close
6.85 
1-M High
8.21 
Volume 
48 
Bid
6.65
Ask
6.88
Day Low
5.75 
Open
6.71 
1-M Low
5.15 
Market Cap 
54.77M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 7.42 
20-SMA 6.57 
50-SMA 6.24 
52-W High 14.0117 
52-W Low 4.16 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.71/-0.86
Enterprise Value
58.55M
Balance Sheet
Book Value Per Share
-0.13
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
25.18M
Operating Revenue Per Share
1.36
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
ABTAbbott Laboratories112.65+3.09+2.82%29.21PE
After Hours 112.65 0 0.00%
BSXBoston Scientific Corp71.9+0.55+0.77%36.78PE
After Hours 71.9 0 0.00%
MDTMedtronic plc91.34+0.44+0.48%25.39PE
After Hours 91.34 0 0.00%
BFLYButterfly Network3.76+0.11+3.01%-- 
After Hours 3.74 -0.02 -0.53%
PACBPacific Biosciences of California1.39+0.01+0.72%-- 
After Hours 1.39 0 0.00%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated withmigraine headache in adult patients, and the prevention of migraine in adult patients, The use of gammaCore by adolescent patients and Treatment of hemicrania continua and paroxysmal hemicrania in adult patients.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.